Post by masders on Feb 15, 2024 8:22:48 GMT
Different types of immunotherapy cause different side effects, depending on the type of cancer location and prescribed therapeutic dose, as well as the general condition of the patient. To prevent and control the unwanted effects of immunotherapy used in the treatment of malignant diseases is the most important task of the team involved in the treatment of malignant disease. First of all, the most important thing is to explain to the patients all possible side effects that can sometimes be in a larger number and require dealing with the side effects with the involvement of the full team of specialists.
Many side effects remain present even after finishing immunotherapy and may be present for several months or even years. HOW CAN It is applied intravenously directly into a vein By drinking tablets or capsules Topically with cream for the treatment of skin carcinomas in the earliest stage Intravesically with the application of the BSG vaccine HOW OFTEN AND HOW LONG IMMUNOTHERAPY Seyces Email List CAN BE TAKEN DEPENDS ON: Type of malignancy The stage of the disease The type of immunotherapy the patient is receiving How the patient responds to immunotherapy Immunotherapy can be taken daily, during the week and during the month. Some immunotherapies are given in cycles, which means there is a period of treatment and then a break. The pause is intended to heal the body, to achieve the response, to achieve the immunotherapy response and the creation of new healthy cells.
WHICH MALIGNANT DISEASES CAN BE TREATED WITH IMMUNOTHERAPY AND WHEN? Taking into account the recent results presented at the largest oncology congresses ASCO and ESMO, it can be concluded that the application of immunotherapy in the treatment of malignant diseases has an increasing application in the treatment of various types of malignant diseases. As adjuvant treatment in advanced stages, as first-line metastatic disease, or when standard first-line therapy is unsuccessful. The role of predictive biomarkers is important in the treatment of immunotherapy, such as the PD-1 antibody, and for the first time we have approved therapy for the treatment of malignant disease on the basis of the biomarker, not according to the origin of the tumor.
Many side effects remain present even after finishing immunotherapy and may be present for several months or even years. HOW CAN It is applied intravenously directly into a vein By drinking tablets or capsules Topically with cream for the treatment of skin carcinomas in the earliest stage Intravesically with the application of the BSG vaccine HOW OFTEN AND HOW LONG IMMUNOTHERAPY Seyces Email List CAN BE TAKEN DEPENDS ON: Type of malignancy The stage of the disease The type of immunotherapy the patient is receiving How the patient responds to immunotherapy Immunotherapy can be taken daily, during the week and during the month. Some immunotherapies are given in cycles, which means there is a period of treatment and then a break. The pause is intended to heal the body, to achieve the response, to achieve the immunotherapy response and the creation of new healthy cells.
WHICH MALIGNANT DISEASES CAN BE TREATED WITH IMMUNOTHERAPY AND WHEN? Taking into account the recent results presented at the largest oncology congresses ASCO and ESMO, it can be concluded that the application of immunotherapy in the treatment of malignant diseases has an increasing application in the treatment of various types of malignant diseases. As adjuvant treatment in advanced stages, as first-line metastatic disease, or when standard first-line therapy is unsuccessful. The role of predictive biomarkers is important in the treatment of immunotherapy, such as the PD-1 antibody, and for the first time we have approved therapy for the treatment of malignant disease on the basis of the biomarker, not according to the origin of the tumor.